Fox Chase Cancer Center News

PHILADELPHIA (February 17, 2025) — Fox Chase Cancer Center is proud to announce the hiring of Jason A. Damsker, MD, FACP, as a Professor in the Department of Hematology/Oncology.

PHILADELPHIA (February 17, 2025) — Many large corporations have used a four-day workweek to attract and retain talent, but does this model work for nurse managers? A new paper by nurse leaders at Fox Chase Cancer Center makes the case that it does.

PHILADELPHIA (February 15, 2025) — A new study presented today by researchers at Fox Chase Cancer Center shows that some patients with metastatic kidney cancer receiving a combination therapy can safely stop or pause treatment after two years if they have a good response.

PHILADELPHIA (February 14, 2025) — Interim analysis of a clinical trial led by Fox Chase Cancer Center researchers shows promise for the treatment of patients with muscle-invasive bladder cancer.

PHILADELPHIA (February 12, 2025) — Fox Chase Cancer Center’s Johnathan Whetstine, PhD, Director of the Cancer Epigenetics Institute, recently joined the editorial board of Genes & Development, a leading, not-for-profit scientific journal that focuses on significant biological advances.

PHILADELPHIA (February 13, 2025) — Fox Chase Cancer Center is pleased to announce the hiring of Michael Noonan, DO, MS, as an Assistant Professor in the Supportive Oncology and Palliative Care Program.

PHILADELPHIA (February 10, 2024) — Jeffrey Farma, MD, FACS, Chair of the Department of Surgery at Fox Chase Cancer Center, and a team of colleagues recently published an updated review of guidelines governing the use of neoadjuvant and adjuvant therapy for patients with melanoma.

PHILADELPHIA (January 31, 2025) — Parth A. Desai, MBBS, MD, Assistant Professor in the Department of Hematology/Oncology at Fox Chase Cancer Center, was recently awarded the 2024 Innovation Award by Ride Hard Breathe Easy, which helps raise awareness and funds for patients being treated for lung cancer.